A-5787 is an introduced bill that would add requirements to New Jersey’s health coverage and Medicaid laws. It would require coverage for certain hormone therapy refills; its stated goal is to authorize that coverage. It has not become law, and the supplied materials do not include the current text of the laws it would supplement, so I could not verify how much of this coverage is already required.
No publicly available information on the bill’s expected public or private cost.
Bills on related subjects, starting with New Jersey.
Lawmakers propose an emergency 30-day insulin supply bill; Department of Banking and Insurance and State Board of Pharmacy would develop an application.
Status
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
The bill would bar health plans, including state and school employee programs, from denying, restricting or delaying drug coverage because a drug received FDA accelerated approval.
Status
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
House bill would direct funds to subsidize exchange coverage for households under 400% FPL with a type 1 diabetes member. A report would cover effects by income and immigration status.
Status
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pharmacists or their designees would have to notify consumers when dispensing substituted drugs or biological products; existing substitution conditions would remain.
Status
Introduced, Referred to Assembly Financial Institutions and Insurance Committee